REGENXBIO Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-55.9M | $-66.9M | $11.0M | $10.8M |
| Jun 2022 | $-61.7M | $-71.0M | $9.2M | $10.3M |
| Sep 2022 | $-50.5M | $-55.5M | $5.1M | $10.2M |
| Dec 2022 | $-39.4M | $-44.8M | $5.5M | $9.4M |
| Mar 2023 | $-80.9M | $-85.7M | $4.8M | $11.2M |
| Jun 2023 | $-47.3M | $-49.9M | $2.6M | $10.5M |
| Sep 2023 | $-49.4M | $-50.8M | $1.4M | $10.2M |
| Dec 2023 | $-40.8M | $-41.9M | $1.1M | $8.3M |
| Mar 2024 | $-55.5M | $-56.0M | $557.0K | $9.6M |
| Jun 2024 | $-45.5M | $-46.0M | $474.0K | $9.4M |
| Sep 2024 | $-40.5M | $-40.9M | $326.0K | $9.9M |
| Dec 2024 | $-31.6M | $-32.7M | $1.1M | $9.5M |
| Mar 2025 | $33.6M | $32.6M | $1.0M | $8.5M |
| Jun 2025 | $-49.3M | $-49.7M | $391.0K | $8.7M |
| Sep 2025 | $-56.0M | $-56.5M | $491.0K | $9.0M |
| Dec 2025 | $-52.3M | $-52.8M | $508.0K | $8.4M |
| Mar 2026 | $-76.2M | $-77.4M | $1.2M | $8.6M |
| Jun 2026 | $-62.2M | $-63.0M | $760.0K | $9.1M |